Progress in diagnosis and treatment of mantle cell lymphoma / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 637-640, 2016.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-503175
Responsible library:
WPRO
ABSTRACT
Mantle cell lymphoma (MCL) is a group of highly aggressive non-Hodgkin lymphoma (NHL) in small B-cell lymphoma, accounting for 6 % of NHL incidence. MCL is characterized with its concealed onset, strong aggression, high malignancy and poor prognosis. Therefore, more attention should be paid to the diagnosis and differential diagnosis of MCL in clinic. Recently, diagnostic models of molecular pathology, researches on cyclin D1 protein negative MCL, staging prognosis and stratification treatment of MCL are worthy of attention.
Full text:
Available
Database:
WPRIM (Western Pacific)
Type of study:
Diagnostic study
Language:
Chinese
Journal:
Journal of Leukemia & Lymphoma
Year:
2016
Document type:
Article